TransCode Therapeutics, Inc. (RNAZ)
NASDAQ
$8.73+3.56%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 14,356
- 52-week high
- —
- 52-week low
- —
- Open
- $8.68
- Day high
- $8.88
- Day low
- $8.45
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$34.66M | -$52.59 |
| 2024 | — | -$16.75M | -$1,336.63 |
| 2023 | — | -$18.55M | -$3,419.01 |
| 2022 | — | -$17.56M | -$1,082.79 |
| 2021 | — | -$6.84M | -$0.81 |
About TransCode Therapeutics, Inc.
A company overview for TransCode Therapeutics, Inc. is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is TransCode Therapeutics, Inc.'s stock price today?
- RNAZ is trading at $8.73 as of Jul 20, 2026.
- Does TransCode Therapeutics, Inc. pay a dividend?
- TransCode Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.